These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34021175)

  • 1. Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers.
    Jacquerie P; Henket M; André B; Moermans C; de Seny D; Gester F; Louis R; Malaise M; Guiot J
    Sci Rep; 2021 May; 11(1):10679. PubMed ID: 34021175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7.
    Guiot J; Henket M; Corhay JL; Moermans C; Louis R
    PLoS One; 2017; 12(2):e0171344. PubMed ID: 28178340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction.
    Guiot J; Njock MS; André B; Gester F; Henket M; de Seny D; Moermans C; Malaise MG; Louis R
    Sci Rep; 2021 May; 11(1):10882. PubMed ID: 34035374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased sputum caveolin-1 is associated with systemic sclerosis related lung disease.
    Yilmaz N; Olgun S; Ahiskali R; Karakurt S; Yavuz S
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Apr; 31(1):55-61. PubMed ID: 24751454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new nucleosomic-based model to identify and diagnose SSc-ILD.
    Guiot J; Henket M; Andre B; Herzog M; Hardat N; Njock MS; Moermans C; Malaise M; Louis R
    Clin Epigenetics; 2020 Aug; 12(1):124. PubMed ID: 32807242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis.
    Sakamoto N; Kakugawa T; Hara A; Nakashima S; Yura H; Harada T; Ishimoto H; Yatera K; Kuwatsuka Y; Hara T; Ichinose K; Obase Y; Ishimatsu Y; Kohno S; Mukae H
    Respir Res; 2015 Dec; 16():148. PubMed ID: 26654954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
    Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cytokines and their predictive value in pulmonary involvement of systemic sclerosis.
    Becker MO; Radic M; Schmidt K; Huscher D; Riedlinger A; Michelfelder M; Meisel C; Ewert R; Burmester GR; Riemekasten G
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(4):274-284. PubMed ID: 32476963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchoalveolar matrix metalloproteinase 9 relates to restrictive lung function impairment in systemic sclerosis.
    Andersen GN; Nilsson K; Pourazar J; Hackett TL; Kazzam E; Blomberg A; Waldenström A; Warner J; Rantapää-Dahlqvist S; Mincheva-Nilsson L; Sandström T
    Respir Med; 2007 Oct; 101(10):2199-206. PubMed ID: 17643278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 cytokines and scleroderma interstitial lung disease.
    Pellicano C; Vantaggio L; Colalillo A; Pocino K; Basile V; Marino M; Basile U; Rosato E
    Clin Exp Med; 2023 Nov; 23(7):3517-3525. PubMed ID: 37392249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity and features of frailty in systemic sclerosis-associated interstitial lung disease.
    Guler SA; Kwan JM; Winstone TA; Milne KM; Dunne JV; Wilcox PG; Ryerson CJ
    Respir Med; 2017 Aug; 129():1-7. PubMed ID: 28732817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms].
    Zhu HL; DU Q; Chen WL; Zuo XX; Li QZ; Liu SJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):716-722. PubMed ID: 31420628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis.
    Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Gornowicz-Porowska J; Katulska K; Trzybulska D; Batura-Gabryel H; Silny W; Poplawski D; Hrycaj P
    Int J Rheum Dis; 2014 Jul; 17(6):664-70. PubMed ID: 24467649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced sputum in systemic sclerosis interstitial lung disease: comparison to healthy controls and bronchoalveolar lavage.
    Damjanov N; Ostojic P; Kaloudi O; Alari S; Guiducci S; Stanflin N; Nestorovic B; Knezevic J; Camiciottoli G; Porta F; Pistolesi M; Ibba-Manneschi L; Conforti ML; Candelieri A; Matucci Cerinic M
    Respiration; 2009; 78(1):56-62. PubMed ID: 18931474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.
    Khanna D; Tashkin DP; Denton CP; Renzoni EA; Desai SR; Varga J
    Am J Respir Crit Care Med; 2020 Mar; 201(6):650-660. PubMed ID: 31841044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Fibronectin Levels in Profibrotic CD14
    Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G
    Front Immunol; 2021; 12():642891. PubMed ID: 34504485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients.
    Schmidt K; Martinez-Gamboa L; Meier S; Witt C; Meisel C; Hanitsch LG; Becker MO; Huscher D; Burmester GR; Riemekasten G
    Arthritis Res Ther; 2009; 11(4):R111. PubMed ID: 19615053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function.
    van den Hombergh WMT; Simons SO; Teesselink E; Knaapen-Hans HKA; van den Hoogen FHJ; Fransen J; Vonk MC
    Clin Rheumatol; 2018 Oct; 37(10):2715-2722. PubMed ID: 29987427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
    Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y
    Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.